Cell signaling

Melanotan II

Melanotan 2 / MT-II / MT2

Peptide length
7 amino acids

Cyclic peptide

Evidence availableLimited or mixed research

Open the sources to check how the studies were done and what they can support.

A synthetic cyclic melanocortin agonist discussed in pigmentation and sexual-response research, with published reports of adverse skin changes.

Family
Melanocortin agonist
Research target
Melanocortin receptors
Molecular form
Cyclic peptide

What to know about the research

Case reports can identify potential harms but cannot estimate their frequency. Results for approved afamelanotide products do not transfer to melanotan II.

Check the exact compound

Distinguish the cyclic structure and terminal chemistry from both melanotan I and bremelanotide.

FOLLOW THE EVIDENCE

What supports this entry?

The reference list is available. A statement-by-statement source check has not been completed for this entry.

These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.

Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.

No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.

How we prepare and correct these entries

Read the research in context

Keep your Melanotan II research together.

Get the compound summary, evidence notes, source links, and a reading checklist in one research pack.

Get my research pack